Graciela Barajas
Nurse Practitioner · Burleson, TXNPI 1194415026
Payments from drug & device makers
Across 86 payments — averaging $21.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$267
- AbbVie$192
- Lilly USA, LLC$151
- Exact Sciences$145
- AstraZeneca$126
- Bayer$115
- plus $833 from 18 others
What the payments were for
- Food & beverage$1,828100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 14 | $267 |
| AbbVie | 10 | $192 |
| Lilly USA, LLC | 9 | $151 |
| Exact Sciences | 8 | $145 |
| AstraZeneca | 7 | $126 |
| Bayer | 6 | $115 |
| Kyowa Kirin, Inc. | 1 | $110 |
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
| Abbott | 3 | $80 |
| Medtronic | 1 | $79 |
| Pfizer | 4 | $79 |
| Boehringer Ingelheim | 3 | $77 |
| Eisai Inc. | 3 | $73 |
| Fidia Pharma USA Inc. | 2 | $37 |
| Averitas Pharma Inc. | 1 | $32 |
| Corium, LLC | 1 | $31 |
| Amgen | 2 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
| GSK | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Viatris Specialty LLC | 1 | $14 |
How this compares
$1,828 in reported general payments places this provider in the 85th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 78 | $85,022 |
| JardianceEmpagliflozin | 39 | $58,913 |
| RybelsusSemaglutide | 18 | $35,028 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $17,265 |
| EliquisApixaban | 18 | $12,405 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $2,559 |
| Vitamin D2Ergocalciferol (Vitamin D2) | 96 | $1,481 |
| Gabapentin | 71 | $1,210 |
| Diclofenac Sodium | 32 | $1,066 |
| Ciclopirox | 22 | $972 |
| Atorvastatin Calcium | 168 | $855 |
| Levothyroxine Sodium | 101 | $853 |
| Lisinopril | 97 | $731 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 35 | $713 |
| Esomeprazole Magnesium | 18 | $707 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $267 | $120,04996 claims |
| Boehringer IngelheimJardiance | $77 | $58,91339 claims |
| GSKTrelegy Ellipta | $17 | $17,26521 claims |
| PfizerEliquis | $79 | $12,40518 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in Burleson
- Hong DoBurleson$18K
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Kelly BrassilHouston$194K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Monica WhiteLongview$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.